BackCullinan Therapeutics Overview
Cullinan Therapeutics Inc

Cullinan Therapeutics Target Price

Analysts' average 12-month price target for Cullinan Therapeutics is $35.

Get informed when a big investor buys or sells

+ Follow

Share Price

$19.64

Average Target Price

$35.3379.9% upside

3 analysts in the last 4 months

High: $39 | Low: $30

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-29BTIG$3998.6% upsideOpen
2026-05-08Wedbush$3788.4% upsideOpen
2026-04-28H.C. WainwrightRobert Burns$3052.7% upsideOpen
2026-03-11Wedbush$3683.3% upsideOpen
2026-03-10Stifel NicolausAlex Thompson$2842.6% upsideOpen
2026-02-02Guggenheim$3052.7% upsideOpen
2026-01-08H.C. Wainwright$2737.5% upsideOpen
2026-01-08Morgan Stanley$3052.7% upsideOpen
2025-12-09WedbushRobert Driscoll$3473.1% upsideOpen
2025-11-24BTIGJulian Harrison$3893.5% upsideOpen
2025-11-20New Street$2632.4% upsideOpen
2024-10-24UBSDavid Dai$3052.7% upsideOpen
2024-08-08Morgan StanleyJeffrey Hung$3893.5% upsideOpen
2024-05-16H.C. WainwrightEdward White$2842.6% upsideOpen
2024-04-17BTIGKaveri Pohlman$3052.7% upsideOpen
2024-04-16H.C. WainwrightEdward White$2947.7% upsideOpen
2023-02-03Morgan Stanley$193.3% downsideOpen

Cullinan Therapeutics (CGEM) FAQ

The latest target price for CGEM is $35. Investors often review this figure alongside Cullinan Therapeutics's historical trend and sector peers before judging valuation or financial health.

Cullinan Therapeutics trades near $19.64 while the consensus target sits at $35 (79.9% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting CGEM's target price ($35), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Cullinan Therapeutics's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.